Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

General

General

Group By Ticker
Sort By
Newest | Oldest
Read More
2 minute read
  • Entertainment
  • General
  • News

Predator Prequel Prey Beats The Kardashians: Here’s What The Hulu Record Could Mean

By Chris Katje
August 11, 11:16 AM
A prequel to an original movie from 1980 is the most watched premiere on Hulu. Here’s a look at how “Prey” stacks up for the Disney-backed streaming platform.

AMZN

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Commodities
  • General
  • Markets
  • Media
  • Topics
  • Trading Ideas

The Inflation Trade ‘Isn’t Dead Yet’: This Analyst Sees 23% Upside On This Energy Play

By AJ Fabino
August 11, 11:02 AM
The Energy Select Sector SPDR Fund (NYSE: XLE) is up 31.09% year-to-date, alongside major energy names like Exxon Mobil Corp (NYSE: XOM) and Chevron Corporation (NYSE:

CVX

Read More
1 minute read
  • Commodities
  • General
  • Markets
  • News
  • Politics

Ukraine Expecting Arrival Of Ship Tomorrow That Will Deliver Over 23,000 Tonnes Of Grain To Ethiopia

By Benzinga Newsdesk
August 11, 10:55 AM
-Reuters

CORN

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Penny Stocks

Passage Bio Commences Initial-Stage Brain Disorder Study

By Ragothaman Srinivasan
August 11, 9:57 AM
Passage Bio (NASDAQ: PASG) has dosed the first patient in the global Phase 1/2 upliFT-D clinical trial evaluating PBFT02 for the treatment of patients with frontotemporal dementia (FTD) with granulin (GRN) mutations.

PASG

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News
  • Small Cap

Deciphera’s Cancer Drug Tops Pfizer’s Sutent On Safety Front In Gastrointestinal Cancer

By Vandana Singh
August 11, 9:45 AM
The Journal of Clinical Oncology has published results from Deciphera Pharmaceuticals Inc (NASDAQ:DCPH) INTRIGUE Phase 3 study of Qinlock (ripretinib) for advanced…

DCPH

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • News
  • Penny Stocks

aTyr Pharma Shares Ascend As FDA Grants Fast Track Status To Lung Disease Candidate

By Ragothaman Srinivasan
August 11, 9:32 AM
The U.S. Food and Drug Administration (FDA) has granted Fast Track designation to aTyr Pharma’s (NASDAQ: LIFE) lead therapeutic candidate, efzofitimod (ATYR1923), for the treatment of pulmonary sarcoidosis, a major form of interstitial lung disease.

LIFE

Read More
1 minute read
  • Earnings
  • General
  • Guidance
  • Health Care
  • Large Cap
  • Management
  • Movers
  • News
  • Trading Ideas

Cardinal Health Names New Chief Executive, Posts Mixed Q4 Earnings

By Vandana Singh
August 11, 8:26 AM
Cardinal Health Inc (NYSE:CAH) has reported Q4 FY22 adjusted EPS of $1.05, up 36% Y/Y, missing the consensus of $1.17.…

CAH

Read More
1 minute read
  • Biotech
  • FDA
  • General
  • News

Menarini Group’s Elacestrant Granted Priority Review By The U.S. FDA For Patients With ER+/HER2- Advanced Or Metastatic Breast Cancer

By Benzinga Newsdesk
August 11, 6:48 AM
Elacestrant, if approved, would be the first oral selective estrogen receptor degrader (SERD) to be available for patients suffering from 2L and 3L ER+/HER2- advanced or metastatic breast

RDUS

Read More
2 minute read
  • General
  • M&A
  • Media
  • News
  • Social Media
  • Tech

Elon Musk’s Lawyers Seek Access To Names Of Twitter Employees Who Count Bot Accounts: Report

By Shanthi Rexaline
August 11, 5:42 AM
While speculation of Elon Musk’s renewed interest in Twitter, Inc. (NYSE: TWTR) is gaining ground, a report suggests that the Tesla, Inc.

TSLA

Read More
2 minute read
  • Commodities
  • Economics
  • General
  • Global
  • Markets
  • News
  • Politics

Putin Is ‘Not Bluffing:’ Analyst Warns Germany Faces ‘Severe Recession’ With Russia Holding Back Gas Supplies

By Navdeep Yadav
August 11, 1:02 AM
Germany has been reeling under the carpet since the beginning of the Russia-Ukraine and the cut down on the gas supplies has come as another major blow to its delicate economy. 

OGZPY

Posts pagination

Previous 1 … 2,244 2,245 2,246 … 2,367 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service